📖

Tau Consortium

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-organizations-tau-consortium

Related Entities

organizations-tau-consortium

Metadata

slug	organizations-tau-consortium
entity_type	organization
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (147)

related🔬Extracellular vesicle biomarkers for early AD detection70%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖Donepezil60%

see_also📖Mitochondria60%

see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%

see_also📖ABI3 Gene60%

see_also📖ADORA1 Gene60%

see_also📖BAG260%

see_also📖CTSZ Gene - Cathepsin Z60%

see_also📖TRIM11 Gene60%

see_also📖VGLUT2 Gene60%

see_also📖VPS29 Gene60%

see_also📖WNT5A Gene60%

see_also📖BAG2 Protein60%

see_also📖donepezil60%

see_also📖spermidine-neurodegeneration60%

see_also📖AT(N) Biomarker Classification for Alzheimer's Disease60%

see_also📖A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di60%

see_also📖Combination Biomarker Panels for Alzheimer's Disease60%

see_also📖Cholinergic Basal Forebrain Neurons in Alzheimer's Dise60%

see_also📖Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disea60%

see_also📖Dentate Gyrus Granule Cells in Alzheimer's Disease60%

see_also📖Disease-Associated Microglia in Alzheimer's Disease60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's 60%

see_also📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea60%

see_also📖Hippocampal Neurons60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease60%

see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%

see_also📖Locus Coeruleus Norepinephrine in AD60%

see_also📖Temporal Cortex Neurons in Alzheimer's Disease60%

see_also📖AMDX-2011P Phase 2 Trial for Alzheimer's Disease60%

see_also📖AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Diseas60%

see_also📖Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT062260%

see_also📖Bilingualism Cognitive Reserve AD Trial60%

see_also📖Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT60%

see_also📖LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Dise60%

see_also📖Methylphenidate + iTBS for Apathy in AD (PRIME Trial)60%

see_also📖MK-1167 Phase 2 Alzheimer's Disease Trial60%

see_also📖Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation60%

see_also📖NCT04840979 - Genetic Variants Affecting Microglial Activati60%

see_also📖NCT07138677: MCI Network Guided TMS for Early Alzheimer'60%

see_also📖RO7812653 for Early Symptomatic Alzheimer's Disease60%

see_also📖TTYP01 Phase 2 Alzheimer's Disease Trial60%

see_also📖XTR006 Tau PET for Alzheimer's Disease (NCT07115238)60%

see_also📖Accelerating Medicines Partnership Alzheimer's Disease 60%

see_also📖Neurodegeneration60%

see_also📖ABCA7 (Redirect)60%

see_also📖Experiment: Autoimmune Hypothesis Testing in AD60%

see_also📖Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

see_also📖SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

see_also📖IQCK — IQ Motif Containing Kinase60%

see_also📖KIF13A Gene60%

see_also📖MAP1S - Microtubule Associated Protein 1S60%

see_also📖STX6 Gene60%

see_also📖TRIM24 — Tripartite Motif Containing 2460%

see_also📖UFM1 — Ubiquitin-like Modifier 160%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Cholinergic Hypothesis in Alzheimer's Disease60%

see_also📖Glia-Neuron Crosstalk in Alzheimer's Disease60%

see_also📖Glymphatic System in Alzheimer's Disease60%

see_also📖Infectious Etiology Hypotheses in Alzheimer's Disease60%

see_also📖Infectious Triggers in Alzheimer's Disease60%

see_also📖Innate Immune Signaling Pathways in Alzheimer's Disease60%

see_also📖Integrated Stress Response in Alzheimer's Disease60%

see_also📖Microglial State Trajectory from Mobilization to Dysregulati60%

see_also📖mitochondrial-dysfunction-ad60%

see_also📖Neuronal Death Pathways in Alzheimer's Disease60%

see_also📖PKM2 Metabolic Dysregulation in Alzheimer's Disease60%

see_also📖psilocybin-neuropsychiatric-ad60%

see_also📖RNA Metabolism Dysregulation in Alzheimer's Disease60%

see_also📖Sleep Disruption in Alzheimer's Disease60%

see_also📖Vascular Contributions to Alzheimer's Disease60%

see_also📖Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)60%

see_also📖CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzh60%

see_also📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise60%

see_also📖HGSNAT Gene60%

see_also📖Neurofibrillary Tangles60%

see_also📖Tauopathies60%

see_also📖VAMP2 Gene - Synaptobrevin-260%

see_also📖VAMP2 Protein60%

see_also📖ABCA2 Gene - ATP Binding Cassette Subfamily A Member 260%

see_also📖14-3-3 Proteins (CSF) - Biomarker60%

see_also📖CSF Biomarkers for Corticobasal Syndrome and Progressive Sup60%

see_also📖CSF Biomarker Comparison Across Neurodegenerative Diseases60%

see_also📖CSF Neurofilament Light Chain (NfL) in Neurodegeneration60%

see_also📖CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitor60%

see_also📖csf-pta18160%

see_also📖CSF Synaptic Biomarker Panel for Neurodegenerative Diseases60%

see_also📖Total Tau (t-tau) in Cerebrospinal Fluid60%

see_also📖CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 60%

see_also📖CSF Cytokine Profiles as Parkinson's Disease Biomarkers60%

see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy60%

see_also📖KCNJ2 — Kir2.1 Inward Rectifier Potassium Channel60%

see_also📖Mitophagy Receptor Pathway in Neurodegeneration60%

see_also📖Microglia in Neurodegeneration60%

see_also📖Mitochondria60%

see_also📖TRKA Gene60%

see_also📖TrkA Protein — Tropomyosin Receptor Kinase A60%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation54%

mentions🔬Extracellular vesicle biomarkers for early AD detection50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%

mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model50%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring50%

mentions🧫Microtubule domain analysis in adult axons50%

mentions🧫Tau depletion effects on neuronal development in primary cul50%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%

mentions🧪Smartphone-Detected Motor Variability Correction50%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an50%

mentions🧪APOE Isoform Conversion Therapy50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬Extracellular vesicle biomarkers for early AD detection50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🧫Experiment: Multi-Ethnic PD GWAS44%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne44%

mentions🧫Creation and validation of 3xAD-ChAT-Cre mouse model44%

mentions🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model44%

mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice44%

mentions🧫TLR expression in α-synuclein overexpressing mice44%

mentions🧫Dexamethasone treatment study in α-synuclein mice44%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%

related🧪Competitive APOE4 Domain Stabilization Peptides40%

related🧪APOE Isoform Expression Across Glial Subtypes40%